| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/10/2011 | US20110035822 Plants with altered root architecture, related constructs and methods involving genes encoding exostosin family polypeptides and homologs thereof |
| 02/10/2011 | US20110035821 Novel tomato plants |
| 02/10/2011 | US20110035819 Codon optimized cftr |
| 02/10/2011 | US20110035818 Diagnostic marker and platform for drug design in myocardial infarction and heart failure |
| 02/10/2011 | US20110035817 Siva 3, its preparation and use |
| 02/10/2011 | US20110035814 Cooperating oncogenes in cancer |
| 02/10/2011 | US20110034758 Cartridge For A Biological Sample |
| 02/10/2011 | US20110034753 Stem cell targeting and activation using magnetic particles |
| 02/10/2011 | US20110034673 Monoclonal antibody capable of binding to heparin-binding epidermal growth factor-like growth factor |
| 02/10/2011 | US20110034546 Methods to produce rod-derived cone viability factor (rdcvf) |
| 02/10/2011 | US20110034545 Double-stranded lipid-modified rna having high rna interference effect |
| 02/10/2011 | US20110034538 MicroRNA-Based Methods and Compositions for the Diagnosis, Prognosis and Treatment of Gastric Cancer |
| 02/10/2011 | US20110034537 Compositions and methods for inhibiting expression of cd45 gene |
| 02/10/2011 | US20110034536 Controlling the potential of primate neural stem cells by regulating pax6 |
| 02/10/2011 | US20110034533 Compositions and methods modulating mg29 for the treatment of diabetes |
| 02/10/2011 | US20110034472 Novel Compounds for Treatment of Cancer and Disorders Associated With Angiogenesis Function |
| 02/10/2011 | US20110034447 Tdp-43-storing cell model |
| 02/10/2011 | US20110034395 Compositions and methods of inhibiting apoptosis |
| 02/10/2011 | US20110034389 Active agents, compositions, and methods for inhibiting and reversing platelet function |
| 02/10/2011 | US20110034386 Dendroaspis natriuretic peptide for treatment of cancer |
| 02/10/2011 | US20110034383 Cxcl12 gamma a chemokine and uses thereof |
| 02/10/2011 | US20110034372 Truncated activin type ii receptor and methods of use |
| 02/10/2011 | US20110034370 Bis-met histones |
| 02/10/2011 | US20110034368 Multiple Gene Expression Including sORF Constructs and Methods with Polyproteins, Pro-Proteins and Proteolysis |
| 02/10/2011 | US20110034344 Response gene to complement 32 (rgc-32) in disease |
| 02/10/2011 | US20110033937 Down-regulation of gene expression using artificial micrornas |
| 02/10/2011 | US20110033936 CANINE iPS CELLS AND METHOD OF PRODUCING SAME |
| 02/10/2011 | US20110033934 Transcriptome Transfer Produces Cellular Phenotype Conversion |
| 02/10/2011 | US20110033933 Method applying hemodynamic forcing and klf2 to initiate the growth and development of cardiac valves |
| 02/10/2011 | US20110033932 Substrate for cell adhesion or culture and method for producing the same |
| 02/10/2011 | US20110033931 De-differentiation of human cells |
| 02/10/2011 | US20110033930 Method for obtaining ngn3-expressing cells and insulin producing-beta cells |
| 02/10/2011 | US20110033929 Uses of antibodies to mammalian dc langerhans cell antigen |
| 02/10/2011 | US20110033928 Methods and compositions for growth of cells and embryonic tissue on a synthetic polymer matrix |
| 02/10/2011 | US20110033927 Methods of generating small-diameter tissue engineered blood vessels |
| 02/10/2011 | US20110033926 Production Of Viral Vectors |
| 02/10/2011 | US20110033925 Cell Separation Method and Apparatus |
| 02/10/2011 | US20110033924 Apparatus and Method for Filtering Biological Material |
| 02/10/2011 | US20110033923 Marker for stem cells and its use |
| 02/10/2011 | US20110033922 Microchip-based acoustic trapping or capture of cells for forensic analysis and related method thereof |
| 02/10/2011 | US20110033921 Bardet-biedl susceptibility gene and uses thereof |
| 02/10/2011 | US20110033911 Episomal fusion gene |
| 02/10/2011 | US20110033903 Isolated population of plant single cells and method of preparing same |
| 02/10/2011 | US20110033895 Method For Producing Human Antibodies With Properties Of Agonist, Antagonist, or Inverse Agonist |
| 02/10/2011 | US20110033891 Mussel bioadhesive |
| 02/10/2011 | US20110033874 Biomarkers |
| 02/10/2011 | US20110033870 Hybridoma producing antibodies to lawsonia intracellularis |
| 02/10/2011 | US20110033868 Use of a nitrated protein or peptide sequence for the implementation of a method of diagnosis |
| 02/10/2011 | US20110033837 Immortalized human cd4-positive cell and its use for determining the phenotype of a human immunodeficiency virus type 1 |
| 02/10/2011 | US20110033604 Soybean Cultivar 83121431 |
| 02/10/2011 | US20110033603 Soybean cultivar 8624001 |
| 02/10/2011 | US20110033523 Use of microvesicles (mvs) derived from stem cells for preparing a medicament for endo/epithellal regeneration of damaged or injured tissues or organs, and related in vitro and in vivo methods |
| 02/10/2011 | US20110033522 Reagents for inducing an immune response |
| 02/10/2011 | US20110033504 Articles and methods for repairing damaged nervous tissue |
| 02/10/2011 | US20110033492 Vaccines for brucellosis |
| 02/10/2011 | US20110033489 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 02/10/2011 | US20110033483 Single-chain multivalent binding proteins with effector function |
| 02/10/2011 | US20110033481 Prospective identification and characterization of breast cancer stem cells |
| 02/10/2011 | US20110033472 Tumor Endothelial Marker 5-alpha Molecules and Uses Thereof |
| 02/10/2011 | US20110033470 Human G-Protein Coupled Receptor |
| 02/10/2011 | US20110033469 Leukotriene b4 binding soluble lipocalin receptor from ixodes ricinus |
| 02/10/2011 | US20110033466 Human transcriptomes |
| 02/10/2011 | US20110033465 Anti-pcsk9 and methods for treating lipid and cholesterol disorders |
| 02/10/2011 | US20110033462 Humanized monoclonal antibodies that specifically bind and/or neutralize japanese encephalitis virus (jev) and their use |
| 02/10/2011 | US20110033456 Methods of therapy for b-cell malignancies using antagonist anti-cd40 antibodies |
| 02/10/2011 | US20110033455 Methods For Inhibiting The Binding Of Endosialin To Ligands |
| 02/10/2011 | US20110033452 Anti-Glypican 3 Antibody Having Modified Sugar Chain |
| 02/10/2011 | US20110033450 Antibody Against Anthrax Toxins |
| 02/10/2011 | US20110033448 Inhibitors of LL-37 Mediated Immune Reactivity to Self Nucleic Acids |
| 02/10/2011 | US20110033443 Method for Increasing Bone Mass |
| 02/10/2011 | US20110033435 Composition of activated CD4 cells |
| 02/10/2011 | US20110033434 Cultured three-dimensional tissues and uses thereof |
| 02/10/2011 | US20110033430 Methods for the induction of a cell to enter the islet 1+ lineage and a method for the expansion thereof |
| 02/10/2011 | US20110033429 Inducible Gene Expression |
| 02/10/2011 | US20110033428 Method for isolating smooth muscle stem cells |
| 02/10/2011 | US20110033427 Expansion Of Renewable Stem Cell Populations |
| 02/10/2011 | US20110033426 Use of modified cells for the treatment of multiple sclerosis |
| 02/10/2011 | US20110033421 Methods related to immunostimulatory nucleic acid-induced interferon |
| 02/10/2011 | US20110033415 Agent for differentiating hematopoietic stem cell into natural killer cell comprising yc-1 or il-2 1 and a method of differentiating hematopoietic stem cell into natural killer cell using the same |
| 02/10/2011 | US20110033393 Hydrazone Compounds and Their Use |
| 02/10/2011 | US20110033391 Transferases and Oxidoreductases, Nucleic Acids Encoding them and methods for making and using them |
| 02/10/2011 | US20110033389 Modified antibodies for passive immunotherapy |
| 02/10/2011 | US20110033383 Methods and compositions for generating an immune response by inducing cd40 and pattern recognition receptors and adaptors thereof |
| 02/10/2011 | US20110033378 Cysteine Engineered Antibodies For Site-Specific Conjugation |
| 02/10/2011 | US20110031391 Method for generation and use of isotopic patterns in mass spectral data of simple organisms |
| 02/10/2011 | DE102008031350B4 Prokaryotische Xylose-Isomerase zur Konstruktion Xylose-vergärender Hefen Prokaryotic xylose isomerase xylose fermenting yeasts for construction |
| 02/10/2011 | CA2806840A1 Method for in vivo expansion of t regulatory cells |
| 02/10/2011 | CA2772326A1 Pairing processes for preparing alloreactive cytotoxic t cells |
| 02/10/2011 | CA2772280A1 Compositions and methods of preparing alloreactive cytotoxic t cells |
| 02/10/2011 | CA2770412A1 Method of efficiently establishing induced pluripotent stem cells |
| 02/10/2011 | CA2769852A1 Islet cell sheet, process for production thereof, and use thereof |
| 02/10/2011 | CA2769651A1 Improved plants, microbes, and organisms |
| 02/10/2011 | CA2768745A1 Beta cell marker antibody |
| 02/10/2011 | CA2768600A1 Vaccine composition comprising 5'-cap modified rna |
| 02/10/2011 | CA2768428A1 Isolated polynucleotides and polypeptides, and methods of using same for increasing abiotic stress tolerance, yield, growth rate, vigor, biormass, oil content, and/or nitrogen useefficiency of plants |
| 02/09/2011 | EP2282207A1 Plasma polymerisation methods for the deposition of chemical gradients and surfaces displaying a gradient of immobilised biomolecules |
| 02/09/2011 | EP2281896A2 Transgenic plant-based methods for plant insect pests using RNAi |
| 02/09/2011 | EP2281894A2 Protein kinase stress-related proteins and methods of use in plants |
| 02/09/2011 | EP2281891A2 Streptococcus antigens |
| 02/09/2011 | EP2281879A1 Method and apparatus for selectively targeting specific cells within a cell population |